Brief: Rovi To Receive 36.3 Mln Euro Grant For Research Into Prolonged-Release Drugs And New Sterile Filling Technologies
08/05/2025 06:58
May 8 (Reuters) - Laboratorios Farmaceuticos ROVI SA ROVI.MC: INFORMS ON AWARD OF GRANT IN ITS FAVOR TO DEVELOP RESEARCH AND DEVELOPMENT PROJECT IPCEI - ROVI (LAISOLID) TO RECEIVE 36.3 MILLION EUROS FOR RESEARCH INTO PROLONGED-RELEASE DRUGS AND NEW STERILE FILLING TECHNOLOGIES Source text: ID:nCNMghX0PF Further company coverage: ROVI.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))